NovoCure Limited (NVCR)
NASDAQ: NVCR · IEX Real-Time Price · USD
18.40
-0.08 (-0.43%)
At close: Jul 19, 2024, 4:00 PM
18.09
-0.31 (-1.68%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
NovoCure Market Cap
NovoCure has a market cap or net worth of $1.98 billion as of July 22, 2024. Its market cap has decreased by -53.93% in one year.
Market Cap
1.98B
Enterprise Value
1.70B
1-Year Change
-53.93%
Ranking
Category
Stock Price
$18.40
Market Cap Chart
Since October 2, 2015, NovoCure's market cap has increased from $1.51B to $1.98B, an increase of 31.02%. That is a compound annual growth rate of 3.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.98B | 24.11% |
| Dec 29, 2023 | 1.60B | -79.28% |
| Dec 30, 2022 | 7.70B | -1.24% |
| Dec 31, 2021 | 7.79B | -55.75% |
| Dec 31, 2020 | 17.62B | 111.21% |
| Dec 31, 2019 | 8.34B | 167.82% |
| Dec 31, 2018 | 3.11B | 72.52% |
| Dec 29, 2017 | 1.81B | 164.99% |
| Dec 30, 2016 | 681.20M | -63.57% |
| Dec 31, 2015 | 1.87B | 23.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 2.09B |
| Rocket Pharmaceuticals | 2.09B |
| Recursion Pharmaceuticals | 2.05B |
| Premier | 2.05B |
| BrightSpring Health Services | 1.99B |
| 10x Genomics | 1.98B |
| Arvinas | 1.98B |
| Catalyst Pharmaceuticals | 1.97B |